The role of N53Q mutation on the rat μ-opioid receptor function

Journal of Biomolecular Techniques

Volumn 21, Issue 2, 2010, Pages 92-96

  Rostami, A ^a   Rabbani, M ^b   Mir Mohammad Sadeghi, M ^b  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cAMP; Glycosylation

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP; MORPHINE; MU OPIATE RECEPTOR;

ARTICLE; DNA VECTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE MUTATION; GENETIC TRANSFECTION; GLYCOSYLATION; N53Q GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRANSIENT EXPRESSION; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL ASSAY; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; ELECTROPHORESIS, AGAR GEL; MORPHINE; MUTATION; RATS; RECEPTORS, OPIOID, MU; STAINING AND LABELING; TRANSFECTION;

RATTUS;

EID: 77955650064     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Petaja-Repo UE, Hogue M, Laperriere A, Walker P, Bouvier M. Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human δ opioid receptor. J Biol Chem 2000;275:13727-13736. (Pubitemid 30257444)
2. Chaturvedi K, Shahrestanifar M, Howells RD. μ Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity. Brain Res Mol Brain Res 2000;76:64-72. (Pubitemid 30133234)
3. Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, Kieffer BL. A single nucleotide polymorphic mutation in the human μ-opioid receptor severely impairs receptor signaling. J Biol Chem 2001;276:3130-3137.
4. Bot G, Blake AD, Li S, Reisine T. Mutagenesis of a single amino acid in the rat μ-opioid receptor discriminates ligand binding. J Neurochem 1998;70:358-365. (Pubitemid 28020863)
5. Brillet K, Kieffer BL, Massotte D. Enhanced spontaneous activity of the μ opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening. BMC Pharmacol 2003;3:14. (Pubitemid 38729264)
6. Saito Y, Tetsuka M, Yue L, Kawamura Y, Maruyama K. Functional role of N-linked glycosylation on the rat melanin-concentrating hormone receptor 1. FEBS Lett 2003;533:29-34.
7. Wang HL, Chang WT, Hsu CY, Huang PC, Chow YW, Li AH. Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of μ-opioid receptors. Biochem Pharmacol 2002;64:257-266.
8. Assil IQ, Abou-Samra AB. N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction. Am J Physiol Endocrinol Metab 2001;281:E1015-E1021.
9. Lanctot PM, Leclerc PC, Clement M, et al. Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the hAT 1 receptor. Biochem J 2005;390:367-376.
10. Nagayama Y, Nishihara E, Namba H, Yamashita S, Niwa M. Identification of the sites of asparagine-linked glycosylation on the human thyrotropin receptor and studies on their role in receptor function and expression. J Pharmacol Exp Ther 2000; 295:404-409.
11. Akiyama SK, Yamada SS, Yamada KM. Analysis of the role of glycosylation of the human fibronectin receptor. J Biol Chem 1989;264:18011-18018.
12. Benya RV, Kusui T, Katsuno T, et al. Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes. Mol Pharmacol 2000;58:1490-1501.
13. Bond C, LaForge KS, Tian M, et al. Single-nucleotide polymorphism in the human μ opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998;95:9608-9613.
14. Fenrick R, McNicoll N, De Lean A. Glycosylation is critical for natriuretic peptide receptor-B function. Mol Cell Biochem 1996; 165:103-109.
15. Lee KH, Ahn JI, Yu DH, et al. Effect of N-glycosylation on ligand binding affinity of rat V1a vasopressin receptor. Biochem Biophys Res Commun 2001;286:707-713.
16. Zhang Z, Austin SC, Smyth EM. Glycosylation of the human prostacyclin receptor: role in ligand binding and signal transduction. Mol Pharmacol 2001;60:480-487.
17. Wenzel-Seifert K, Seifert R. Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor. Biochem Biophys Res Commun 2003;301:693-698.
18. Rabbani M, Sadeghi HM, Jafarian-Dehkordi A, Hajhashemi V, Rostami A. N53Q site directed mutagenesis of rat mu opioid receptor and its cloning using pcDNA3 vector. Pak J Biol Sci 2005;8:1115-1118.
19. Luthman H, Magnusson G. High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res 1983; 11:1295-1308.
20. Sadeghi HM, Innamorati G, Birnbaumer M. An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol Endocrinol 1997;11:706-713.
21. Avidor-Reiss T, Zippel R, Levy R, et al. κ-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. FEBS Lett 1995; 361:70-74.
22. Massi P, Vaccani A, Rubino T, Parolaro D. Cannabinoids and opioids share cAMP pathway in rat splenocytes. J Neuroimmunol 2003;145:46-54.
23. Tso PH, Wong YH. G(z) can mediate the acute actions of μ- and κ-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization. J Pharmacol Exp Ther 2000;295:168-176.
24. Ammer H, Christ TE. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity. J Neurochem 2002;83:818-827.
25. Bailey CP, Connor M. Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 2005;5:60-68.
26. Zhong X, Kriz R, Seehra J, Kumar R. N-linked glycosylation of platelet P2Y12 ADP receptor is essential for signal transduction but not for ligand binding or cell surface expression. FEBS Lett 2004;562:111-117.
27. Kelley LP, Kinsella BT. The role of N-linked glycosylation in determining the surface expression, G protein interaction and effector coupling of the α (α) isoform of the human thromboxane A(2) receptor. Biochim Biophys Acta 2003;1621:192-203.
28. Mody N, Hermans E, Nahorski SR, Challiss RA. Inhibition of N-linked glycosylation of the human type 1α metabotropic glutamate receptor by tunicamycin: effects on cell-surface receptor expression and function. Neuropharmacol 1999;38:1485-1492.
29. Nehring RB, Richter D, Meyerhof W. Glycosylation affects agonist binding and signal transduction of the rat somatostatin receptor subtype 3. J Physiol Paris 2000;94:185-192.